AtriCure, Inc.
ATRC- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001323885
In the last 90 days, AtriCure, Inc. insiders filed 0 open-market purchases and 7 sales; 251 institutions reported holding it in 13F filings for Q2 2026, worth $1.47B in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 10, 2026
- $2.86B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $2.32M in total
- 7
- 13F holdersQ2 2026, +28 vs. previous quarter
- 251
- 13F valueReported value at the end of Q2 2026
- $1.47B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $534.5M
- +14.9% year over year
- Net income, FY2025
- -$11.4M
- No comparable prior period
- Free cash flow, FY2025
- $48.3M
- +6,381.1% year over year
- Revenue, Q3 FY2026
- $154.4M
- +15.0% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $11.4M (2.1% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 4.89M
- Shares sold short
- Change
- +3.40K
- +0.1% vs. previous
- Days to cover
- 7.60
- At average daily volume
Superinvestors holding ATRC, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding ATRC at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by AtriCure, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2026 (view filing)4:02 PM ET | Nov 6 | 4 days | Johnson B KristineDirector | SSale | −2.45K | $58.48 | −$143.4K | −4.4%53.5K after | |
| Nov 5, 2026 (view filing)4:17 PM ET | Nov 4 | 1 day | Privitera SalvatoreChief Technical Officer | SSale | −8.40K | $65.00 | −$546.3K | −5.9%134.3K after | 10b5-1 |
| Sep 24, 2026 (view filing)5:00 PM ET | Sep 23 | 1 day | Privitera SalvatoreChief Technical Officer | SSale | −4.52K | $60.00 | −$271.1K | −3.1%142.7K after | 10b5-1 |
| Sep 14, 2026 (view filing)5:44 PM ET | Sep 11 | 3 days | Groves Regina EDirector | SSale | −5.31K | $54.22 | −$288.1K | −13.3%34.5K after | |
| Sep 10, 2026 (view filing)9:18 AM ET | Sep 8 | 2 days | Privitera SalvatoreChief Technical Officer | SSale | −3.66K | $55.00 | −$201.1K | −2.4%147.3K after | 10b5-1 |
| Sep 4, 2026 (view filing)7:39 AM ET | Sep 2 | 2 days | Privitera SalvatoreChief Technical Officer | SSale | −7.76K | $52.50 | −$407.6K | −4.9%150.9K after | 10b5-1 |
| Aug 26, 2026 (view filing)6:50 AM ET | Aug 24 | 2 days | Dahlquist Karl S.Chief Legal Officer | SSale | −9.37K | $48.89 | −$458.1K | −9.7%87.3K after | |
| Aug 7, 2026 (view filing)9:18 AM ET | Aug 5 | 2 days | Prange KarenDirector | SSale | −3.56K | $38.80 | −$138.3K | −13.5%22.8K after | |
| Aug 7, 2026 (view filing)9:18 AM ET | Aug 5 | 2 days | Yuen MaggieDirector | SSale | −3.50K | $38.42 | −$134.5K | −20.0%14.0K after | |
| Jul 30, 2026 (view filing)4:57 PM ET | Jul 28 | 2 days | Doraiswamy VinayakChief Scientific Officer | SSale | −6.00K | $38.88 | −$233.3K | −6.5%86.5K after |
Top 10 13F holders, Q2 2026
See all 251 holdersThe largest institutional positions in AtriCure, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,474,548 | $125.2M | 0.00% | +431,867+10.7% | Added |
| Wellington Management Group LLP | 3,495,603 | $97.8M | 0.02% | +113,048+3.3% | Added |
| Vanguard Portfolio Management LLC | 3,127,195 | $87.5M | 0.00% | +424,563+15.7% | Added |
| Hood River Capital Management LLC | 2,905,299 | $81.3M | 0.59% | −212,246−6.8% | Reduced |
| Alliancebernstein L.P. | 2,768,365 | $79.0M | 0.03% | −490,507−15.1% | Reduced |
| Vanguard Capital Management LLC | 2,190,413 | $61.3M | 0.00% | +34,649+1.6% | Added |
| Nomura Asset Management International Inc. | 1,734,279 | $48.5M | 0.07% | −70,648−3.9% | Reduced |
| Goldman Sachs Group Inc | 1,597,988 | $44.7M | 0.00% | −69,178−4.1% | Reduced |
| State Street Corp | 1,389,989 | $38.9M | 0.00% | +87,827+6.7% | Added |
| Marshall Wace, LLP | 1,333,904 | $37.3M | 0.03% | −133,620−9.1% | Reduced |
Holders of 5% or more of ATRC
See all 6 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of AtriCure, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 15.40%7.84M shares | +7.60 ppfrom 7.80% | Oct 17, 20252 filings | Oct 5, 2026 | SEC |
| Vanguard Portfolio Management LLC | 13G/A | 7.22%3.68M shares | +1.71 ppfrom 5.51% | Apr 28, 20262 filings | Oct 30, 2026 | SEC |
| Wellington Management Group LLP | 13G/A | 6.80%3.38M shares | −1.20 ppfrom 8.00% | Aug 12, 20252 filings | May 15, 2026 | SEC |
| Hood River Capital Management LLC | 13G/A | 6.23%3.10M shares | +0.23 ppfrom 6.00% | Nov 14, 20243 filings | Feb 17, 2026 | SEC |
| Alliancebernstein L.P. | 13G/A | 5.50%2.77M shares | – | Feb 14, 20224 filings | Aug 14, 2026 | SEC |
Politician trades
All politician trades in ATRC2 members of Congress reported 10 trades in AtriCure, Inc. since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Oct 12, 2026 |  Gilbert Ray Cisneros, Jr. House · CA | Sell (partial) | $1K-$15K |
| Sep 10, 2026 | Gilbert Ray Cisneros, Jr. House · CA | Buy | $1K-$15K |
| Apr 7, 2026 | Gilbert Ray Cisneros, Jr. House · CA | Buy | $1K-$15K |
| Jun 6, 2025 | Gilbert Ray Cisneros, Jr. House · CA | Buy | $1K-$15K |
| Aug 15, 2024 |  Josh Gottheimer House · NJ | Buy | $1K-$15K |
House · CA · Oct 12, 2026
Sell (partial)$1K-$15K
House · CA · Sep 10, 2026
Buy$1K-$15K
House · CA · Apr 7, 2026
Buy$1K-$15K
House · CA · Jun 6, 2025
Buy$1K-$15K
House · NJ · Aug 15, 2024
Buy$1K-$15K